Sporadic acute lymphocytic leukemia arising in a patient with neurofibromatosis and xanthogranulomatosis

Cancer Investigation

Volumn 14, Issue 2, 1996, Pages 109-111

  Deb, Giovanni ^a   Habetswallner, Daniela ^a   Helson, Lawrence ^b   De Sio, Luigi ^a   Caniglia, Maurizio ^a   Donfrancesco, Alberto ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CASE REPORT; CHILD; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; XANTHOGRANULOMA;

EID: 0029914288     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609018885     Document Type: Article

References (19)

1. Riccardi VM: Von Recklinghausen neurofibromatosis. N Engl J Med 305(27):1617-1627, 1981.
2. Stern J, Jakobiec FA, Houspian A: The architecture of optic nerve gliomas with and without neurofibromatosis. Arch Ophthalmol 98:505-511, 1980.
3. Sorensen SA, Mulvhill JJ, Nielsen A: A clinical pathological and genetic study of multiple neurofibromatosis: Survival and malignant neoplasms. N Engl J Med 314(16):1010-1014, 1986.
4. Riccardi VN: Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr 22:66-106, 1992.
5. Lilleyman J, Hann I, Stevens R, et al: French American British (FAB) morphological classification of childhood lymphoblastic leukemia and its clinical importance. J Clin Pathol 39:998-1002, 1986.
6. Riehm H, Gadner H, Henze G, et al: The five therapy trials ALL-BFM 1970-1986: A synopsis of results. Am Soc Clin Oncol 6:162, 1987 (abstract).
7. Rissau C, Couter N, Sette MR, et al: High dose L- asparaginase in a randomized fashion in addition to a BFM protocol for treatment of childhood acute lymphoblastic leukemia (ALL): Impact on duration of a therapeutic phase and side effects. Med Pediatr Oncol 21:557, 1993.
8. Stokkel MPM, Kroon BBR, van der Sandle JJ, et al: Malignant cutaneous melanoma associated with neurofibromatosis in two sisters from a family with familial atypical multiple mole melanoma syndrome. Cancer 72(8):2370-2375, 1993.
9. Sordillo PP, Helson L, Hadju SI, et al: Malignant schwannoma: Clinical characteristics, survival, and response to therapy. Cancer 47:2503-2509, 1981.
10. Kanedo Y, Maseki N, Sakurai M, et al: Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome and acute leukemia associated with neurofibromatosis. Leukemia 3:36-41, 1989.
11. Bollag LI, Clark R, Conroy L, et al: Somatic mutations in the neurofibromatosis gene in human tumors. Cell 69:275-281, 1992.
12. Shannon KM, Watterson J, Johnson P, et al: Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: Epidemiology and molecular analysis. Blood 79:1311-1318, 1992.
13. Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 92:926-929, 1978.
14. Skuse GR, Kosciolek BA, Rpwwley PT: Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: Loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer 1:36-41, 1989.
15. Matsui I, Tanimura M, Kobayashi N, et al: Neurofibromatosis type 1 and childhood cancer. Cancer 72(9):2746-2754, 1993.
16. Bos JL: ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689, 1989.
17. Royer P, Blondet C, Guihard J: Xantholeucemie du nourrission et neurofibromatose de Recklinghausen. Ann Pediatr 24:1504-1513, 1958.
18. Morier P: Juvenile chronic granulocytic leukemia, juvenile xanthogranulomas, and neurofibromatosis. J Am Acad Dermatol 22:962-965, 1990.
19. Hope DG, Mulvhill JJ: Malignancy in neurofibromatosis. Adv Neurol 29:33-56, 1981.